期刊文献+

论著p53基因突变与非霍奇金淋巴瘤病因学关系研究 被引量:3

Study on p53 gene mutations in non-Hodgkin's lymphomas
下载PDF
导出
摘要 目的:研究p53基因突变在非霍奇金淋巴瘤(NHL)发生发展中的作用。方法:在37例非霍奇金淋巴瘤组织中采用PCR-单链构象多态性分析法(PCR-SSCP)进行p53基因外显子5~8的突变检测。结果:p53基因总突变率为54.1%,惰性组、侵袭性组、高侵袭性组突变率分别为0.0%、58.1%、100.0%;T和NK细胞组和B细胞组突变率分别为37.5%、58.6%。结论:非霍奇金淋巴瘤中存在p53基因的突变,p53基因的突变在NHL的发展演变中可能起重要作用。 Objective:To evaluate the mutation of p53 gene in pathogenesis of non-Hodgkin's lymphoma. Methods:Thirty-seven cases of non-Hodgkin's lymphoma were studied for frequency of p53 gene mutation in exon 5 to 8 with PCR-SSCP method. Results:In 37 cases of non-Hodgkin's lymphoma ,the frequency of p53 genie mutation was 54.1%. The the frequency of p53 genie mutation was detected in indolent(0.0%),aggressive(58.6%) and highly aggressive group(100.0%). The incidence of p53 genie mutation in T/NK cell lymphoma and B cell lymphoma was 37.5% and 58.6%, respectively. Conclusion:The mutation of p53 gene is present in NHL. Mutation of p53 gene might play a key role in pathogenesis and progression of lymphoma.
出处 《现代医药卫生》 2008年第9期1268-1269,共2页 Journal of Modern Medicine & Health
基金 国家自然科学基金资助项目(30160030)
关键词 非霍奇金淋巴瘤 P53基因 突变 Non-Hodgkin's lymphoma p53 gene Mutation
  • 相关文献

参考文献4

  • 1Werness BA, Wang HQ,Chance J,et al. p53-independent expression of p21waf1/cipl in preinvasive and invasive squamous neoplasms of the uterine cervix[J].Mod Pathol, 1997,10(6):578.
  • 2Jaffe ES,Harris NL,Stein H,et al. World Health Organization Classification of Tumours. Patholory and genetics of turnouts of haemato- poietic and lymphoid tissues[J].IARC Press:Lyon 2001.
  • 3陈岗,何开玲,许良中.48例非霍奇金淋巴瘤中的p53基因突变[J].上海医科大学学报,1995,22(4):242-244. 被引量:3
  • 4Dyke TV.p53 and tumor suppression[J]. N Engl J Med, 2007.356.

共引文献2

同被引文献17

  • 1尹丽霞,张伟京.B细胞非霍奇金淋巴瘤重要相关基因的研究进展[J].国外医学(药学分册),2006,33(3):174-177. 被引量:3
  • 2罗春英,邓飞.非霍奇金淋巴瘤中p53基因突变情况研究[J].右江民族医学院学报,2006,28(5):712-714. 被引量:3
  • 3Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a P^53- inducible regulator of glycolysis and apoptosis. Cell, 2006, 126 (1) : 107-120.
  • 4Tai YC, Tan JMA, Pet SC. Higher frequency of p^53 gene mutations in diffuse large B-cell lymphoma with MALT component.Pathology international, 2004, 54 (11) : 811-815.
  • 5Jezersek-Novakovic B, Frkovic-Grazio S, Novakovic S. The immunohistochemical and serological determination of p^53 protein in patients with malignant lymphomas. Neoplasma, 2002, 49 ( 1 ) : 16-20.
  • 6Pagnono KB, Vassallo J, Loran M, et al. p^53 mdm and c-myc overexpression is associated with a poor prognosis in aggressive non- Hodkin's lymphomas. AmJ Hematol, 2001, 67 ( 2 ) : 84-02.
  • 7Polyak K, Xia Y, Zweler JL, et al. A model for P^53-induced apoptosis. Nature, 1997, 389 (6648) : 300-305.
  • 8Kon i kov 6 E, KusendaJ. Altered expression of P^53 and MDM2 proteins inhematologicalmalignandes. Neoplasma, 2003, 50 ( 1 ) : 31-40.
  • 9Contente A, Dittmer A, Koch MC, et al. A polymorphic microsatellite that mediates induction of PIG-3 by p^53. Nat Genet, 2002, 30 (3) : 315-320.
  • 10赵宝玉,边大鹏,汪欣,汤坚强,万远廉,刘玉村,吴涛,潘义生,王鹏远.原发性胃肠道淋巴瘤的诊断与治疗[J].中国肿瘤临床与康复,2007,14(5):446-449. 被引量:14

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部